Skip to content

QLIPP-CIPN: Effectiveness of online Acceptance and Commitment Therapy for pain interference in cancer survivors with chronic painful chemotherapy-induced neuropathy (CIPN)

QLIPP-CIPN: Effectiveness of online Acceptance and Commitment Therapy for pain interference in cancer survivors with chronic painful chemotherapy-induced neuropathy (CIPN) - Effectiveness of online ACT for cancer survivors with chronic painful CIPN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54077
Enrollment
146
Registered
2021-10-18
Start date
2022-01-06
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced peripheral neuropathy neuropathy

Interventions

An online ACT intervention was developed in the first phase of the QLIPP-CIPN study. In this study phase insights into daily limitations and quality of life of the patient population were gained, wh

Sponsors

Universiteit van Tilburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18 years or older - Cancer patient or survivor - Chemotherapy ended at least 6 months ago - Identified by a clinician/self as having painful sensations bilaterally in the feet/legs and/or hands for at least 3 months. Neuropathic pain may present as aching, burning, **pins-and-needles,** and/or shock-like, and also covers painful tingling, numbness and/or cramps. - Scoring a 4 or higher on an 11-point Numeric Rating Scale (NRS). - Pain was not present prior to receiving chemotherapy but related temporally to the initiation of chemotherapy.

Exclusion criteria

Exclusion criteria: - New chemotherapy scheduled during study involvement - Very low scores on psychological inflexibility (PIPS; more than 1 SD below mean of population of chronic pain patients in pain rehabilitation centers. These participants already scored highly beneficial on the expected working mechanism of treatment which will lead to ceiling effects) - No access to the Internet at home/no email address - Not enough time to follow the intervention (2hours per week) - Problems with Dutch language - Enrollment in cancer, pain, or psychiatric related treatment upon entry

Design outcomes

Primary

MeasureTime frame
Pain interference in daily life: Multidimensional Pain Inventory (MPI) - subscale Interference.

Secondary

MeasureTime frame
Pain intensity: 11-point Numeric Rating Scale (NRS), Psychological distress: Hospital Anxiety and Depression Scale (HADS), Quality of life: EORTC QLQ-C30, CIPN symptom severity: EORTC QLQ - CIPN20 , Psychological flexibility: Psychological Inflexibility in Pain Scale (PIPS), Freiburg Mindfulness Inventory (FMI-NL), Values-based Living: Engaged Living Scale (ELS), Pain Catastrophizing: Pain Catastrophizing Scale (PCS ).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)